VENABLE LLP for OCHSNER CLINIC FOUNDATION DBA OCHSNER HEALTH
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Medicare and Medicaid inpatient and outpatient policies; health care workforce; 340B drug pricing program; maternal health; health equity and health disparities; value-based care; digital medicine and health care innovation; tobacco cessation; funding for health systems COVID relief
| Lobbyist | Covered position, as disclosed |
|---|---|
| MIKE BLOOMQUIST New | General Counsel, Joint Select Committee on Deficit Reduction |
| JODIE CURTIS New | — |
| ILISA HALPERN PAUL New | — |
Medicare/Medicaid MMM
Medicare and Medicaid inpatient and outpatient policies; health care workforce; 340B drug pricing program; maternal health; health equity and health disparities; value-based care; digital medicine and health care innovation; tobacco cessation; funding for health systems COVID relief
| Lobbyist | Covered position, as disclosed |
|---|---|
| MIKE BLOOMQUIST New | General Counsel, Joint Select Committee on Deficit Reduction |
| JODIE CURTIS New | — |
| ILISA HALPERN PAUL New | — |
Health Issues HCR
Medicare and Medicaid inpatient and outpatient policies; health care workforce; 340B drug pricing program; maternal health; health equity and health disparities; value-based care; digital medicine and health care innovation; tobacco cessation; funding for health systems COVID relief
| Lobbyist | Covered position, as disclosed |
|---|---|
| MIKE BLOOMQUIST New | General Counsel, Joint Select Committee on Deficit Reduction |
| JODIE CURTIS New | — |
| ILISA HALPERN PAUL New | — |
Budget/Appropriations BUD
Medicare and Medicaid inpatient and outpatient policies; health care workforce; 340B drug pricing program; maternal health; health equity and health disparities; value-based care; digital medicine and health care innovation; tobacco cessation; funding for health systems COVID relief
| Lobbyist | Covered position, as disclosed |
|---|---|
| MIKE BLOOMQUIST New | General Counsel, Joint Select Committee on Deficit Reduction |
| JODIE CURTIS New | — |
| ILISA HALPERN PAUL New | — |
Tobacco TOB
Medicare and Medicaid inpatient and outpatient policies; health care workforce; 340B drug pricing program; maternal health; health equity and health disparities; value-based care; digital medicine and health care innovation; tobacco cessation; funding for health systems COVID relief
| Lobbyist | Covered position, as disclosed |
|---|---|
| MIKE BLOOMQUIST New | General Counsel, Joint Select Committee on Deficit Reduction |
| JODIE CURTIS New | — |
| ILISA HALPERN PAUL New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.